95 related articles for article (PubMed ID: 2164819)
1. Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir.
de Gans J; Portegies P; Tiessens G; Troost D; Danner SA; Lange JM
AIDS; 1990 May; 4(5):421-5. PubMed ID: 2164819
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
Parente F; Bianchi Porro G
Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
[TBL] [Abstract][Full Text] [Related]
3. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
Manfredi R; Mastroianni A; Coronado OV; Chiodo F
Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
[TBL] [Abstract][Full Text] [Related]
4. CMV retinitis treated with ganciclovir [9(1,3-dihydroxy-2-propoxymethyl) guanine] in patients with AIDS.
Bach MC; Hedstrom PS
Ann Ophthalmol; 1987 Oct; 19(10):369-73,375. PubMed ID: 2825580
[TBL] [Abstract][Full Text] [Related]
5. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction.
Dieterich DT; Poles MA; Dicker M; Tepper R; Lew E
Am J Gastroenterol; 1993 Apr; 88(4):542-8. PubMed ID: 8385880
[TBL] [Abstract][Full Text] [Related]
6. Predominance of polymorphonuclear leukocytes in cerebrospinal fluid of AIDS patients with cytomegalovirus polyradiculomyelitis.
de Gans J; Tiessens G; Portegies P; Tutuarima JA; Troost D
J Acquir Immune Defic Syndr (1988); 1990; 3(12):1155-8. PubMed ID: 2173744
[TBL] [Abstract][Full Text] [Related]
7. Foscarnet treatment in various cytomegalovirus infections.
Brockmeyer NH; Hengge UR; Mertins L; Malessa R; Steinmetz R; Gooss M
Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):204-7. PubMed ID: 8388868
[TBL] [Abstract][Full Text] [Related]
8. [Cytomegalovirus infections in AIDS].
Raffi F
Rev Prat; 1995 Mar; 45(6):733-8. PubMed ID: 7754312
[TBL] [Abstract][Full Text] [Related]
9. Management of cytomegalovirus infection in patients with acquired immunodeficiency syndrome.
Pau AK; Pitrak DL
Clin Pharm; 1990 Aug; 9(8):613-31. PubMed ID: 2167189
[TBL] [Abstract][Full Text] [Related]
10. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculomyelitis in patients with AIDS.
Karmochkine M; Molina JM; Scieux C; Welker Y; Morinet F; Decazes JM; Lagrange P; Schnell L; Modai J
Am J Med; 1994 Aug; 97(2):196-7. PubMed ID: 8059788
[No Abstract] [Full Text] [Related]
12. [Clinical value of a polymerase chain reaction on cytomegalovirus DNA in cerebrospinal fluid in HIV patients with neurological symptoms].
Roedel C; Grob R; Ruef C
Schweiz Med Wochenschr; 1995 Apr; 125(17):846-53. PubMed ID: 7740295
[TBL] [Abstract][Full Text] [Related]
13. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
Mylonakis E; Kallas WM; Fishman JA
Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS.
Duker JS; Robinson M; Anand R; Ashton P
Ophthalmic Surg Lasers; 1995; 26(5):442-8. PubMed ID: 8963859
[TBL] [Abstract][Full Text] [Related]
15. Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.
Przepiorka D; Ippoliti C; Panina A; Goodrich J; Giralt S; van Besien K; Mehra R; Deisseroth AB; Andersson B; Luna M
Bone Marrow Transplant; 1994 Apr; 13(4):461-4. PubMed ID: 8019472
[TBL] [Abstract][Full Text] [Related]
16. [Lumbosacral polyradiculomyelitis caused by cytomegalovirus in a patient with acquired immunodeficiency syndrome].
Reñé R; Mascaró J; Pérez JL; Bolao F; Martínez-Matos JA; Podzamczer D
Med Clin (Barc); 1992 Apr; 98(13):499-501. PubMed ID: 1316528
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.
Einsele H; Hebart H; Kauffmann-Schneider C; Sinzger C; Jahn G; Bader P; Klingebiel T; Dietz K; Löffler J; Bokemeyer C; Müller CA; Kanz L
Bone Marrow Transplant; 2000 Apr; 25(7):757-63. PubMed ID: 10745262
[TBL] [Abstract][Full Text] [Related]
18. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
[TBL] [Abstract][Full Text] [Related]
19. Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.
Bacigalupo A; van Lint MT; Tedone E; Moro F; Sanna MA; Longren M; Trespi G; Frassoni F; Occhini D; Gualandi F
Bone Marrow Transplant; 1994 Jun; 13(6):753-8. PubMed ID: 7920310
[TBL] [Abstract][Full Text] [Related]
20. Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy.
Anders HJ; Weiss N; Bogner JR; Goebel FD
J Infect; 1998 Jan; 36(1):29-33. PubMed ID: 9515665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
